Lataa...
Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
BACKGROUND: The benefit of ivabradine as an adjunctive therapy to conventional treatment in patients with heart failure (HF) with reduced ejection fraction (HFrEF) is a reduction in both cardiovascular death and HF hospitalization. This study aimed to analyze the cost-effectiveness of ivabradine plu...
Tallennettuna:
| Julkaisussa: | Clinicoecon Outcomes Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901001/ https://ncbi.nlm.nih.gov/pubmed/31824183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S226568 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|